Pharmacokinetic profiles of sitafloxacin in patients with renal dysfunction

Japanese Journal of Chemotherapy

Volumn 56, Issue , 2008, Pages 21-24

  Nakashima, Mitsuyoshi ^a   Kawada, Yukimichi ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

clinical trial; pharmacokinetics; renal dysfunction; sitafloxacin

Indexed keywords

SITAFLOXACIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG HALF LIFE; DRUG SAFETY; HUMAN; KIDNEY FAILURE; MAXIMUM PLASMA CONCENTRATION; PATIENT CARE; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; UNSPECIFIED SIDE EFFECT;

EID: 43449128856     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1995.56.Supplement1_21     Document Type: Article

References (1)

1. Nakashima M, Uematsu T, Kosuge K, Umemura K, Hakusui H, Tanaka M : Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers. An-timicrob Agents Chemother 1995; 39 : 170-4